CHARM-Overall研究PPT课件.pptVIP

CHARM-Overall:Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Overall Purpose To determine whether the angiotensin II receptor blocker candesartan reduces all-cause mortality in patients with chronic heart failure (CHF) Reference Pfeffer MA, Swedberg K, Granger CB, et al. for the CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759–66. CHARM-Overall:Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidit